Health Canada unveils changes aimed at lower drug costs

Review board can now consider whether the price of a drug reflects its value for patients

Prescription pills. THE CANADIAN PRESS/Graeme Roy

Ottawa is overhauling how it regulates the cost of patented medicines, including ending comparisons to the U.S. — changes that Canada’s health minister is billing as the biggest step towards lower drug prices in a generation.

Health Canada’s long-awaited amendments to patented medicine regulations, unveiled Friday, include allowing the arm’s-length Patented Medicine Prices Review Board to consider whether the price of a drug reflects the value it has for patients.

The list of countries that the quasi-judicial board uses to compare prices and gauge its own levels will no longer include the U.S. and Switzerland, both of which are home to some of the highest drug prices in the world.

That’s a category that has also long included Canada, something Health Minister Ginette Petitpas Taylor said she’s determined to change.

“If we look at their health care system, and we also look at the economies … it is really hard to compare their health care system to what we have here in Canada,” Petitpas Taylor said in an interview.

“When we changed the basket of countries, we changed them because we wanted to make sure could compare ourselves to similar jurisdictions that have similar health care systems and also similar populations.”

Jane Philpott, Petitpas Taylor’s predecessor in the portfolio, announced in May 2017 the government was embarking on a series of consultations on a suite of proposed regulatory changes related to the drug prices board.

Philpott said the prices review board — first created 30 years ago to ensure companies do not use monopolies to charge excessive costs — was limited in its ability to protect consumers from high drug prices. The government expressed at the time it hoped to have the new regulations in place no later than the end of 2018.

It has taken a long time for the final changes to be put in place, Petitpas Taylor acknowledged, but she said that’s only because the government wanted to ensure it consulted with all industry stakeholders, patient groups, and people who worked in the field.

RELATED: U.S. to set up plan allowing prescription drugs from Canada

She anticipates the amendments announced Friday will save Canadians approximately $13 billion over 10 years on patented drug costs, and called it a “huge step” towards a national pharmacare plan — the public, single-payer system of drug coverage Prime Minister Justin Trudeau has promised to pursue.

NDP Leader Jagmeet Singh, whose party appears poised to make its own proposal for a national plan a central component of its election campaign, dismissed Friday’s announcement as little more than a stall tactic.

“The best way Canada can lower the price of drugs is well documented: buying them in bulk using the negotiating power of a 37-million-person single-payer pharmacare plan,” Singh said in a statement.

READ MORE: 731,000 Canadians going into debt to buy prescription drugs, UBC says

“But big pharmaceutical and insurance companies don’t want that, so after meeting with them more than 700 times since 2015, Trudeau’s Liberals are stalling pharmacare, and therefore making life easier for big pharma.”

Innovative Medicines Canada, which represents the pharmaceutical industry, warned in a statement that the regulatory amendments would limit the access of Canadian patients to new, cutting-edge treatments, and would also discourage investment in Canada’s life science sector.

Kristy Kirkup, The Canadian Press

Like us on Facebook and follow us on Twitter

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Apex Mountain hosting memorial run for Brayden Kuroda

Kuroda, a Penticton native and World Cup freestyle skier, passed away Monday night at the age of 19.

Online crime reporting coming to Penticton

Penticton RCMP will launch an online crime reporting tool for public use at the end of March.

AlleyCATS Okanagan: Pet of the week

Meet Softy a five-year-old Himalayan cat available for adoption

Jewelry stolen in Oliver, RCMP seek leads

RCMP say both antique pieces have significant sentimental value to the owner.

Penticton MLA urges government to address fatal stretch of Hwy 97

“People are being injured and lives are being lost on this stretch of highway.” - MLA Dan Ashton

Okanagan divers ready to take on 2020 B.C. Winter Games

The athletes have been training four days a week

Galchenyuk nets shootout winner as Wild edge Canucks 4-3

Vancouver tied with Calgary for second spot in NHL’s Pacific Division

B.C.’s soda drink tax will help kids lose weight, improve health, says doctor

Dr. Tom Warshawski says studies show sugary drinks contribute to obesity

A&W employees in Ladysmith get all-inclusive vacation for 10 years of service

Kelly Frenchy, Katherine Aleck, and Muriel Jack are headed on all-expenses-paid vacations

B.C. mom’s complaint about ‘R word’ in children’s ministry email sparks review

In 2020, the ‘R’ word shouldn’t be used, Sue Robins says

B.C., federal ministers plead for meeting Wet’suwet’en dissidents

Scott Fraser, Carolyn Bennett says they can be in Smithers Thursday

COLUMN: Democracies don’t always have to agree

In no democratic system of governance is there ever 100 per cent agreement on any issue

EDITORIAL: Revisiting cannabis regulations

Recent retail license application has brought up concerns about present policy in Summerland

Guidelines regulate Summerland cannabis stores

The municipality’s policy, 300.6 establishes the 50-metre buffer zone around schools and parks

Most Read